The recent listing of koala populations as endangered across much of their range has highlighted the need for better management interventions. Disease is a key threat to koala populations but currently there is no information across the threatened populations on the distribution or impact of a gammaherpesvirus, phascolarctid gammaherpesvirus 1 (PhaHV-1). PhaHV-1 is known to infect koalas in southern populations which are, at present, not threatened. Current testing for PhaHV-1 involves lengthy laboratory techniques that do not permit quantification of viral load. In order to better understand distribution, prevalence and impacts of PhaHV-1 infections across koala populations, diagnostic and rapid point of care tests are required. We have developed two novel assays, a qPCR assay and an isothermal assay, that will enable researchers, clinicians and wildlife managers to reliably and rapidly test for PhaHV-1 in koalas. The ability to rapidly diagnose and quantify viral load will aid quarantine practices, inform translocation management and guide research into the clinical significance and impacts of PhaHV-1 infection in koalas.
CITATION STYLE
Wright, B. R., Jelocnik, M., Casteriano, A., Muir, Y. S. S., Legione, A. R., Vaz, P. K., … Higgins, D. P. (2023). Development of diagnostic and point of care assays for a gammaherpesvirus infecting koalas. PLoS ONE, 18(6 JUNE). https://doi.org/10.1371/journal.pone.0286407
Mendeley helps you to discover research relevant for your work.